Picture of Bioatla logo

BCAB — Bioatla News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapNeutral

Bioatla Inc expected to post a loss of 70 cents a share - Earnings Preview

* Bioatla Inc  BCAB.OQ   BCAB.O  is expected to show a rise
in
quarterly revenue when it reports  results on March 23. 
    * The San Diego California-based  company is expected to
report
revenue of $1.5 million, according to the mean estimate from 6
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for Bioatla Inc is for
a loss
of 70 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bioatla Inc
is
$22​, above​ its last closing price of $2.45. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Sep. 30 2022  -0.80       -0.80      -0.69     Beat    13.8
 Jun. 30 2022  -0.70       -0.69      -0.77     Missed  -12.3
 Mar. 31 2022  -0.67       -0.67      -0.65     Beat    3​
 Dec. 31 2021  -0.63       -0.63      -0.62     Beat    1.2
 ​​Sep.        -0.63       -0.64      -0.68     Missed  -5.7
 30 2021                                                
 Jun. 30 2021  -0.60       -0.58      -0.90     Missed  -53.9​
 Mar. 31 2021  -0.49       -0.52      -0.56     Missed  -7.1
 Dec. 31 2020  -0.78       -0.78      -1.50     Missed  -92.6
 This summary was machine generated March 21 at 20:30 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Bioatla

See all news